This list is an analysis based on recent market events. It's not an investment recommendation.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.
FAQs
What is Gemina Laboratories stock price today?▼
The current price of GLAB.CN is C$0.03 CAD — it has increased by +0% in the past 24 hours. Watch Gemina Laboratories stock price performance more closely on the chart.
What is Gemina Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange Gemina Laboratories stocks are traded under the ticker GLAB.CN.
Is Gemina Laboratories stock price growing?▼
GLAB.CN stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Gemina Laboratories has showed a -92.41% decrease.
What is Gemina Laboratories market cap?▼
Today Gemina Laboratories has the market capitalization of 2.3M
What is Gemina Laboratories revenue for the last year?▼
Gemina Laboratories revenue for the last year amounts to 21,000 CAD.
What is Gemina Laboratories net income for the last year?▼
GLAB.CN net income for the last year is -2.34M CAD.
How many employees does Gemina Laboratories have?▼
As of November 2, 2026, the company has 6 employees.
In which sector is Gemina Laboratories located?▼
Gemina Laboratories operates in the Health & Wellness sector.
When did Gemina Laboratories complete a stock split?▼
Gemina Laboratories has not had any recent stock splits.
Where is Gemina Laboratories headquartered?▼
Gemina Laboratories is headquartered in Burnaby, Canada.